Sun Pharmaceuticals unveils its first-ever corporate brand initiative in the Indian market
Sun Pharmaceutical Industries (Sun Pharma) has launched a corporate brand campaign titled “Touching 1,000 Lives Every Minute” to highlight its role in supporting patients, caregivers, doctors, pharmacists, and communities. The campaign showcases the company’s commitment to innovation, access to medicine, and patient care. With 1,000 Sun Pharma medicines prescribed every minute worldwide, the company reinforces its position as India’s top pharmaceutical company.
The campaign is an integrated, multi-platform effort that spans television, digital, social media, IPL on OTT, and outdoor media to ensure maximum reach. To cater to regional differences, the campaign is being launched in nine languages, including Hindi, Tamil, Telugu, Kannada, Malayalam, Marathi, Bengali, Gujarati, and English. The brand activations will also extend to doctors, pharmacists, and distributors across India, acknowledging Sun’s partnership with these stakeholders to make a positive impact on communities.
According to Kirti Ganorkar, CEO of Sun Pharma’s India Business, the campaign reflects the company’s meaningful impact on people’s lives. With over 40 years of trust in India, the company feels a sense of responsibility to care and serve better. The campaign aims to highlight Sun Pharma’s role in improving people’s health and well-being.
The campaign was crafted by Ogilvy & Mather, Mumbai, with the goal of creating awareness and building affinity and trust among everyday consumers and stakeholders. Prem Narayan, Chief Strategy Officer at Ogilvy India, noted that while Sun Pharma enjoys immense trust among doctors and the medical fraternity, everyday consumers are not as aware of the company’s presence and largeness. The campaign seeks to change this by showcasing Sun Pharma’s commitment to healthcare and its impact on people’s lives.
Overall, the “Touching 1,000 Lives Every Minute” campaign is a significant effort by Sun Pharma to strengthen its brand and reinforce its position as a leader in the pharmaceutical industry. By highlighting its commitment to innovation, access to medicine, and patient care, the company aims to build trust and affinity among its stakeholders and make a positive impact on communities.
Emerging Trends and Investment Prospects in the Global Influenza Treatment Market
The Influenza Therapeutics Market report by Coherent Market Insights provides a comprehensive analysis of the market trends, drivers, challenges, and competitive landscape. The report is a valuable resource for industry leaders, investors, and decision-makers, offering insights into the market size, revenue, production, and CAGR. The market has experienced rapid growth due to rising demand and innovation, and this analysis provides actionable strategies backed by real data.
The report covers the market scope, including product types, applications, end-user markets, key regions, and leading competitors. It assesses the financial performance of key players, including gross profits, sales volumes, and manufacturing costs. The report also uses analytical tools like SWOT analysis and Porter’s Five Forces to evaluate market dynamics.
The Influenza Therapeutics Market is projected to experience substantial growth from 2025 to 2032, with major players adopting strategic initiatives to drive growth. The report highlights key industry players, their innovations, and business strategies, and identifies the most promising long-term growth opportunities.
The report provides a comprehensive segmentation of the market, including by drug type (antivirals and vaccines), virus type (influenza virus type-A and type-B), and age group (pediatrics and adults). The geographical landscape of the market is also analyzed, covering North America, Europe, Asia-Pacific, South America, and the Middle East and Africa.
The report discusses the factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. It highlights emerging trends and changing dynamics, and provides a forward-looking perspective on various factors that are expected to boost the market’s overall growth.
Key benefits of the report include quantitative analysis of market segments, trends, estimations, and dynamics, insights into key drivers, restraints, and opportunities, and Porter’s Five Forces analysis for strategic decision-making. The report also provides segmentation analysis to identify market opportunities, revenue mapping of major countries by region, and benchmarking and positioning of market players.
The report is available for purchase, and buyers can receive a 25% discount with a limited-time offer. The report is delivered through secondary research, direct stakeholder interviews, and expert validation, providing actionable insights for businesses to make informed, strategic moves.
Live Updates Q4 2025: Earnings reports expected today from key companies including Titan, L&T, Asian Paints, Britannia, Biocon, and more.
The fiscal fourth quarter earnings season is currently underway, with numerous large, mid, and small cap companies having already released their Q4 results. Major IT companies such as Tata Consultancy Services, Infosys, Wipro, and HCL Tech, as well as other prominent firms like Reliance Industries, Paytm, and SBI, have reported their Q4 performance.
Today, a range of companies including Titan Company, Larsen & Toubro, Biocon, Asian Paints, Britannia Industries, and Canara Bank are scheduled to release their Q4 results. An analysis report by Nuvama predicts that top-line growth for the fourth quarter will be 6% year-over-year (YoY) for their coverage universe, excluding oil marketing companies (OMCs), which is lower than the 8% YoY growth reported in Q3FY25.
The report notes that this will be the eighth consecutive quarter of sub-10% top-line growth. While the top line has been subdued in both FY24 and FY25, the factors contributing to this are different. In FY24, exports and low-end consumption weakened, whereas in FY25, BFSI, discretionary consumption, and capex slowed.
In terms of sector performance, Nuvama forecasts that the top line will be strong in certain sectors such as electronics manufacturing services (EMS), internet, non-banking financial companies (NBFCs), quick service restaurants (QSR), and consumer services, with growth exceeding 15% YoY. Moderate growth of 10-15% YoY is expected in sectors like durables, fast-moving consumer goods (FMCG), pharma, retail, industrials, and non-lending financials. However, sectors like IT, banks, metals, energy, paints, and cement are expected to report weak growth of less than 10% YoY.
As the earnings season continues, investors and analysts will be closely watching the performance of these companies to gauge the overall health of the economy and specific sectors. The Q4 results will provide valuable insights into the trends and growth prospects of various industries and companies, helping investors make informed decisions. With many companies still to report their Q4 numbers, the earnings season is expected to remain in focus in the coming days.
Apollo Cradle and Apollo One Join Forces in Electronic City, Marking a New Era in Comprehensive Family Healthcare Services
Apollo Cradle and Apollo One have joined forces to launch a state-of-the-art healthcare facility in Electronic City, a major hub for technology and innovation in India. This union marks a significant milestone in the realm of family healthcare, as two renowned healthcare providers come together to offer comprehensive and integrated medical services. The new facility aims to redefine the standards of healthcare in India, providing patients with a seamless and personalized experience.
Apollo Cradle, a trusted name in maternity and childcare, and Apollo One, a prominent player in primary and specialty care, have combined their expertise to create a one-stop destination for families. The new facility will offer a wide range of services, including obstetrics, gynecology, pediatrics, internal medicine, and specialty care, all under one roof.
The union of Apollo Cradle and Apollo One is built on a shared vision to provide high-quality, patient-centric care that addresses the unique needs of families. The new facility will feature advanced medical equipment, cutting-edge technology, and a team of experienced doctors and healthcare professionals. Patients can expect personalized attention, timely interventions, and a compassionate approach to care.
The launch of this facility in Electronic City is strategic, given the area’s growing population and increasing demand for quality healthcare services. The facility is designed to cater to the needs of the local community, providing easy access to medical care and promoting health and wellness.
The union of Apollo Cradle and Apollo One is a significant development in the Indian healthcare landscape, as it demonstrates a commitment to collaboration and integration in the pursuit of excellence. By combining their strengths and expertise, these two healthcare providers aim to create a new paradigm in family healthcare, one that prioritizes patient satisfaction, safety, and outcomes.
In conclusion, the partnership between Apollo Cradle and Apollo One in Electronic City marks a new chapter in family healthcare in India. With a focus on comprehensive, integrated, and patient-centric care, this facility is poised to set a new standard in healthcare delivery, redefining the way medical services are provided to families in India. As the healthcare landscape continues to evolve, this union serves as a shining example of collaboration and innovation, paving the way for a brighter future in Indian healthcare.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.